Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
F18 FBPA PET/CT Imaging in Solid Tumors
NCT07691775Phase 2Recruiting
- Sponsor
- Heron Neutron Medical
- Start
- May 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 2 trial of 4-borono-2-[18F]fluoro-L-phenylalanine in solid tumor, sponsored by Heron Neutron Medical. Started May 2026; status: recruiting.
02
Drugs
4-borono-2-[18F]fluoro-L-phenylalanine
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07691775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07691775.